Valuation: Allied Corp.

Market Cap 1.3M 1.14M 1.05M 976K 1.85M 124M 1.88M 12.57M 4.89M 61.01M 4.89M 4.79M 210M P/E 2023
-2.13x
P/E 2024 -2.52x
Enterprise Value 7.55M 6.6M 6.07M 5.65M 10.73M 719M 10.89M 72.83M 28.31M 353M 28.34M 27.74M 1.22B EV / Sales 2023
394,366,816x
EV / Sales 2024 171,944,593x
Free-Float
52.84%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer 71 -
Corporate Officer/Principal - 2020-05-01
Director TitleAgeSince
Director/Board Member - 2020-05-01
Director/Board Member - -
Director/Board Member - 2024-10-20
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-5.00% - - 117
+0.69%+3.46%+332.15%+16.27% 2.71B
+2.52%+14.79%+154.69%+149.49% 1.88B
0.00%-0.57%-22.33%+111.82% 455M
+18.37%+20.83%+28.89%+45.00% 62.42M
Average +3.32%+10.45%+123.35%+80.64% 1.28B
Weighted average by Cap. +1.52%+9.23%+231.54%+74.19%

Financials

2023 2024
Net sales 0.07 0.06 0.06 0.05 0.1 6.86 0.1 0.7 0.27 3.37 0.27 0.26 11.63 0.1 0.08 0.08 0.07 0.14 9.16 0.14 0.93 0.36 4.5 0.36 0.35 15.51
Net income -10.68M -9.33M -8.58M -7.99M -15.16M -1.02B -15.39M -103M -40.03M -500M -40.07M -39.21M -1.72B -3.98M -3.48M -3.19M -2.98M -5.65M -379M -5.73M -38.35M -14.91M -186M -14.93M -14.6M -641M
Net Debt 5.65M 4.94M 4.54M 4.23M 8.03M 538M 8.15M 54.51M 21.19M 265M 21.21M 20.76M 912M 6.25M 5.46M 5.02M 4.68M 8.87M 595M 9.01M 60.26M 23.42M 292M 23.45M 22.95M 1.01B
Logo Allied Corp.
Allied Corp. is an international medical cannabis production company. The Company is engaged in researching, creating, and producing targeted cannabinoid health solutions. It focuses on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinson’s disease, Tourette’s syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI). Its core hemp-derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. The Tactical Relief brand's flagship product is a hemp-derived CBD tincture for sale in the United States. The Equilibrium Bio brand is primarily focused on hydration and recovery areas. The MaXXa brand develops natural CBD-infused cosmetics and beauty products.
Employees
-